Antihypertensive Drug Therapy for Mild to Moderate Hypertension During Pregnancy - ...
Oct 1, 2019 - Compared with placebo, antihypertensive drug therapy for mild to moderate hypertension (defined by the authors as a blood pressure of 140 to 169 mm Hg systolic or 90 to 109 mm Hg diastolic) caused by chronic hypertension, gestational hypertension, or preeclampsia during pregnancy does ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2019/1001/p403.html
Medication Management for Chronic Heart Failure with Preserved Ejection Fraction - ...
Jul 1, 2019 - Mineralocorticoid receptor antagonists reduce hospitalizations for patients with HFpEF. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers have not been shown to change the morbidity or mortality in patients with HFpEF.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2019/0701/p17.html
Blood Pressure Targets for Patients with Hypertension and Cardiovascular Disease - ...
Sep 1, 2018 - Achieving a target BP of 135/85 mm Hg or less does not decrease the risk of total cardiovascular events vs. treating to a target of 140 to 160/90 to 100 mm Hg. Further, treating to the lower BP target does not improve total mortality, cardiovascular mortality, or serious adverse effects.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2018/0901/p276.html
Effectiveness of PPAR Gamma Agonists in Preventing Recurrent Stroke and Other Vascular ...
Sep 1, 2020 - PPAR gamma agonists are probably effective in preventing recurrent stroke in people with previous stroke or TIA.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2020/0901/p271.html
navigate_before 1 navigate_next